H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!
03 déc. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Successfully Completes Phase 1 and Initiates Phase 2 Clinical Trials with Interferon Alpha-2b in COVID-19 Patients in Chile
29 nov. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife Obtains TD-0148A Behavioural Pharmacology Data Confirming its Projected Non-hallucinogenic Property
16 nov. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Developing Psychedelic Medicine Beyond What We Already Know!
05 nov. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 05, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Obtains TD-0148A In Vitro Pharmacology Data Confirming its Activity in Key Receptors Implicated in Depression and Neuropathic Pain
04 nov. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Early Results of BetterLife Preclinical Study Show AP-003 (rhIFN⍺2b) Provides Up to 97% Protection in Human Cells Against the Delta Variant of SARS-CoV-2
12 oct. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging biotech company focused on...
BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling Pharmacology Studies
29 sept. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
27 sept. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 Trial in Chile
22 sept. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly owned...
BetterLife to Present at the Emerging Growth Conference on September 15, 2021
13 sept. 2021 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotechnology company...